EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analysis of Ferric Protoporphyrin IX Effects on Human Platelets: Hematin Is a More Potent Agonist than Hemin

Diana M Mikhailova iD, Julia Sudnitsyna iD, Polina Kovgan, Lidia Naida, Alexandra Kharazova, Igor Mindukshev iD, Stepan Gambaryan iD

Cells · 2025

DOI: 10.3390/cells14040255 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Diana M Mikhailova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 44 Thorez Ave., 194223 Saint Petersburg, Russia. Hauptthemen laut MEDLINE: Hemin, Blood Platelets, Protoporphyrins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Russian Scientific Foundation, the State Assignment of the Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemolysis during severe diseases (malaria, hemorrhagic stroke, sickle cell disease, etc.) and blood transfusion induces the release of free hemoglobin, which degrades to highly reactive and toxic compounds—hemin and hematin. Oxidized heme derivatives induce platelet activation, aggregation, and degranulation, leading to prothrombotic and inflammatory events. In the present study, we showed that hematin is a more potent agonist of platelet activation than hemin, and using several methods, including the original laser diffraction method, flow cytometry, and confocal microscopy, we demonstrated that hematin at low doses induces platelet activation and aggregation without reducing cell viability and affecting calcium efflux. On the contrary, hematin at high concentrations triggered phosphatidylserine exposure, severe loss of platelet viability, and calcium dysregulation, which was not inhibited by cGMP/PKG and cAMP/PKA pathways. Additionally, we showed that albumin could initiate disaggregation processes in hematin-activated platelets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HeminBlood PlateletsProtoporphyrinsHumansCalciumPlatelet AggregationPlatelet ActivationCell Survival

Stichwörter der Autor:innen

aggregationalbuminhematinheminlaser diffractionplateletsshape change

Substanzen

HeminProtoporphyrinsCalciumiron protoporphyrin IX

Autor:innen und Institutionen

  • Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 44 Thorez Ave., 194223 Saint Petersburg, Russia.
  • Department of Cytology and Histology, Saint Petersburg State University, 7/9 Universitetskaya Emb., 199034 Saint Petersburg, Russia.
  • Institute of Biomedical Systems and Biotechnologies, Peter the Great Saint Petersburg Polytechnic University, 195251 Saint Petersburg, Russia.

ORCID-Profile: Diana M Mikhailova, Julia Sudnitsyna, Igor Mindukshev, Stepan Gambaryan

Förderung

  • the Russian Scientific Foundation
  • the State Assignment of the Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Mikhailova, D. M., Sudnitsyna, J., Kovgan, P., Naida, L., Kharazova, A., Mindukshev, I., & Gambaryan, S. (2025). Analysis of Ferric Protoporphyrin IX Effects on Human Platelets: Hematin Is a More Potent Agonist than Hemin. Cells. https://doi.org/10.3390/cells14040255

Vancouver

Mikhailova DM, Sudnitsyna J, Kovgan P, Naida L, Kharazova A, Mindukshev I, et al. Analysis of Ferric Protoporphyrin IX Effects on Human Platelets: Hematin Is a More Potent Agonist than Hemin. Cells. 2025. doi:10.3390/cells14040255

BibTeX
@article{Mikhailova2025,
  author = {Mikhailova, Diana M and Sudnitsyna, Julia and Kovgan, Polina and Naida, Lidia and Kharazova, Alexandra and Mindukshev, Igor and Gambaryan, Stepan},
  title = {Analysis of Ferric Protoporphyrin IX Effects on Human Platelets: Hematin Is a More Potent Agonist than Hemin},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14040255}
}
Kostenlos starten →